Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Depigmentation Therapy of Refractory Facial Vitiligo Using 532-Nm Picosecond Laser: Two Case Reports and Literature Review

The 532-nm picosecond laser, followed by topical hydroquinone, appears to be an effective and well-tolerated approach for managing residual pigmentation in vitiligo.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report two patients with stable generalized vitiligo who received 532-nm picosecond laser treatment for residual pigmented macules, followed by 2% hydroquinone cream for one to two months. Marked reduction in residual pigmentation was observed in both, with mild erythema and burning that resolved within a week. The study is a small case report series that also includes a literature review.

Participants
2
Who or what was studied
Two patients with stable generalized vitiligo and residual pigmented macules after refractory disease
Wavelengths
532 nm
Limits stated in the abstract
Only two patients were reported, with no control group and no formal outcome measures stated in the abstract.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Vitiligo is a common depigmenting disorder resulting from the loss of functional melanocytes. In certain refractory cases, conventional therapies fail to achieve complete repigmentation, leaving residual pigmented macules that can be cosmetically undesirable.

Aims

To assess the efficacy and safety of 532-nm picosecond laser combined with hydroquinone cream for treating residual pigmentation in vitiligo.

Patients

We report two patients with stable generalized vitiligo who received 532-nm picosecond laser treatment for residual pigmented macules. Patients subsequently applied 2% hydroquinone cream for 1-2 months. Clinical outcomes and adverse events were recorded. Written informed consent was obtained from both patients.

Results

Marked reduction in residual pigmentation was observed in both patients, with cosmetically favorable outcomes. Mild erythema and burning sensation occurred immediately after treatment and resolved within 1 week.

Conclusions

The 532-nm picosecond laser, followed by topical hydroquinone, appears to be an effective and well-tolerated approach for managing residual pigmentation in vitiligo. This reverse depigmentation strategy may serve as a valuable adjunct to enhance skin tone uniformity in selected patients.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies